In 2011, a study on PBMC (Peripheral Blood Mononuclear Cells) identified that the deregulation of CAVB, along with the other seven genes, can be used to discriminate between pancreatic cancer patients and healthy people [80], highlighting, in this way, a role of CAVB in cancer recognition. This evidence concerns the gene CA5B and familial pancreatic carcinoma.